Racemic Salsolinol and its Enantiomers Act as Agonists of the µ-Opioid Receptor by Activating the Gi Protein-Adenylate Cyclase Pathway.

Berríos-Cárcamo, Pablo; Quintanilla, María E; Herrera-Marschitz, Mario; Vasiliou, Vasilis; Zapata-Torres, Gerald; Rivera-Meza, Mario.

Afiliação

Berríos-Cárcamo P; Program of Molecular and Clinical Pharmacology, Faculty of Medicine, Institute of Biomedical Sciences, University of ChileSantiago, Chile; Department of Environmental Health Sciences, Yale School of Public HealthNew Haven, CT, USA.
Quintanilla ME; Program of Molecular and Clinical Pharmacology, Faculty of Medicine, Institute of Biomedical Sciences, University of Chile Santiago, Chile.
Herrera-Marschitz M; Program of Molecular and Clinical Pharmacology, Faculty of Medicine, Institute of Biomedical Sciences, University of Chile Santiago, Chile.
Vasiliou V; Department of Environmental Health Sciences, Yale School of Public Health New Haven, CT, USA.
Zapata-Torres G; Department of Analytical and Inorganic Chemistry, Faculty of Chemical and Pharmaceutical Sciences, University of Chile Santiago, Chile.
Rivera-Meza M; Department of Pharmacological and Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences, University of Chile Santiago, Chile.

Front Behav Neurosci ; 10: 253, 2016.

Article em En | MEDLINE | ID: mdl-28167903